[image credit: IBM]
Aggressive forms of cancer are harder to study
Glioblastoma is one of the most aggressive forms of brain cancer, killing over 13,000 patients each year. Normally, a diagnosis of glioblastoma presents a prognosis of about a year to live, depending on the stage and spread of the cancer at the time. This includes the difficult period of interpreting the best treatment based on the knowledge and information at hand.
Solution: Deploy a supercomputer to analyze data faster
IBM and NYGC's computational biology experts are renowned for accelerating life sciences discoveries using deep analytical approaches and next generation information technologies.
New York Genome Center (NYGC) and IBM are collaborating to analyze genetic data to accelerate the race to personalized, life-saving treatment for brain cancer patients.
IBM's Watson cognitive computing system will be designed to analyze the genomic data from a small group of patients diagnosed with glioblastoma.
The Watson system is designed to complement rapid genome sequencing and to help dramatically reduce the time from gathering the genomic data of an individual's tumor variant to clinical interpretation, enabling clinicians to more rapidly make decisions on how they can treat their patients.
Oncologists could use the cloud-delivered system in real-time to analyze genetic data with the intelligent machine curation of comprehensive biomedical literature and drug databases. This analysis can help pinpoint potential therapeutic options that are specific to a patient’s cancer genome, to aid oncologists in their treatment and care decisions.
RSS - Posts